“Real-World Effectiveness of Up to 12-Month Tralokinumab Treatment in Adults With Atopic Dermatitis Who Previously Discontinued Dupilumab or Janus Kinase Inhibitors”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s728, https://doi.org/10.25251/wx06pe13.